Clinical Trial Update: An Investigational Scan (68Ga-PSMA-11 PET) for the Imaging of Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for an investigational imaging tracer 68Ga-PSMA-11 used to image prostate cancer; the study is currently ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 68Ga-PSMA-11 (Gallium-68 labeled PSMA-11 radiopharmaceutical)

Snippet

Sponsor: University of Washington | Conditions: Biochemically Recurrent Prostate Carcinoma, Metastatic Castration-Resistant Prostate Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING